Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Multicentrisk evaluering af forbedret gendannelse efter operationsprotokol i ungdoms idiopatisk skolioseoperation (EMRACSIA)

23. september 2026 opdateret af: Hospices Civils de Lyon

Adolescent idiopathic scoliosis is a deformation of the spine affecting 2 to 4% of under 18 years old population. This can have severe physical or psychological impact during adulthood. The deformation causes mechanical constraints resulting in early osteoarthritis, which results in adulthood disability.

There is also an impact on the respiratory function in most severe cases of idiopathic scoliosis. Adolescents affected by a scoliosis with an angle of 40° of more undergo a surgery called posterior fusion during adolescence to limit these impacts.

In France, more than 1000 adolescent patients undergo a surgery called posterior spinal fusion for their severe scoliosis.

This aims to straighten the spine by bone grafting all the vertebras included in the scoliosis. Two metal rods are implanted to favour osteosynthesis of the straight spine.

This intervention suffer of a bad image and worries the patients and their parents, as it needs metal implants near the spinal cord.

The worry comes from the most severe complication that may happen exceptionally following this surgery, which is a definitive paraplegia. The scar is quite large and the surgery reduces the mobility of a part of the spine. The intervention produces a quite large haemorrhage, which leads to a diminution in haemoglobin level, resulting in a fatigue during the following weeks.

On the following days, the patient will need a specific protocol of pain management including morphine-based and anti-inflammatory drugs.

This intervention will often require a 5 to 7 days hospitalization with a 1 to 2 month convalescence period at home or in rehabilitation centre.

This intervention is performed on adolescent patients without comorbidities. Moreover, the surgical approach is not profound passing between the para-vertebral muscles with no close large blood vessels or major organs. The pain is caused by correction tensions and the access to the vertebras during the surgery.

Surgical techniques have considerably evolved allowing shorter interventions and to reduce the loss of blood.

The association between morphine-based treatments and grade I analgesics enables an effective pain management.

This intervention appears to perfectly suit to an enhanced recovery after surgery procedure (ERAS).

ERAS is a set of procedure meant to enhance its tolerance and to reduce its morbidity and the hospitalization duration after surgery and the recovery duration.

ERAS is well developed in adult patients undergoing surgery, it is also well described in paediatric patient especially on adolescent scoliosis surgeries.

As the pain is well controlled during the hospitalization as well when the patient get back home, there are very few obstacles to an ERAS procedure in this indication for a patient without comorbidities.

Numerous articles report experiences of medical staff with ERAS protocols.

Generally, the set of measures includes:

  • Before surgery: Providing information and therapeutic patient education, iron supplementation, physiotherapy, skin disinfection, digestive preparation against constipation
  • During surgery: recuperations of blood cells to limit blood loss, use of modern tools to facilitate the positioning of pedicle screws, surgery performed by 2 surgeons
  • After surgery: Pain management until stopping of analgesics by patient and maintenance of a link between the patient at home and the hospital staff after end of hospitalization The articles published about ERAS reports a favourable experience of such protocols with an efficient pain management, reduced hospitalization durations without increasing morbidity or re-hospitalizations. However, no studies have studied and proved by a robust scientific method the benefits of ERAS in adolescent scoliosis.

No studies evaluate the patients' quality of life or follow the patient for more than 6 months after surgery (limiting the assessment of long term complications e.g. infectious complications).

The link between hospital staff and the patient after his return back home is not described as well.

This research project aims to confirm with a robust scientific approach that ERAS protocols in idiopathic scoliosis in adolescents allow to reduce the duration of hospitalization compared to standard of care procedures while improving quality of life after surgery.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

316

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • Amiens, Frankrig, 80054
        • Rekruttering
        • CHU d'Amiens Site Sud
        • Kontakt:
        • Ledende efterforsker:
          • Richard GOURON, MD
      • Besançon, Frankrig, 25000
        • Rekruttering
        • CHU de Besançon Hopital Jean Minjoz
        • Kontakt:
        • Ledende efterforsker:
          • Jeremie NALLET, MD
      • Bron, Frankrig, 69677
        • Rekruttering
        • Pediatric orthopedic surgery unit Hôpital femme Mère Enfant (HFME)
        • Kontakt:
        • Ledende efterforsker:
          • Vincent CUNIN, MD
      • La Tronche, Frankrig, 38700
        • Rekruttering
        • CHU de Grenoble Hôpital Couple Enfant
        • Kontakt:
        • Ledende efterforsker:
          • Aurélien COURVOISIER, MD
      • Lyon, Frankrig, 69322
        • Rekruttering
        • Centre Medico-Chirurgical de Réadaptation des Massues Croix-Rouge
        • Ledende efterforsker:
          • Kariman ABELIN-GENEVOIS, MD
        • Kontakt:
      • Marseille, Frankrig, 13005
        • Rekruttering
        • AP-HM Hôpital de la Timone
        • Kontakt:
        • Ledende efterforsker:
          • Sebastien PESENTI, MD
      • Nice, Frankrig, 06200
        • Rekruttering
        • Fondation LENVAL
        • Kontakt:
        • Ledende efterforsker:
          • Frederico SOLLA, MD
      • Saint-Priest-en-Jarez, Frankrig, 42270
        • Rekruttering
        • CHU de Saint-Etienne Hôpital Nord
        • Kontakt:
        • Ledende efterforsker:
          • Elie HADDAD, MD
      • Toulouse, Frankrig, 31059
        • Rekruttering
        • CHU de Toulouse
        • Kontakt:
        • Ledende efterforsker:
          • Tristan LANGLAIS, MD
      • Toulouse, Frankrig, 31100
        • Rekruttering
        • Clinique Médipôle Garonne
        • Kontakt:
        • Ledende efterforsker:
          • Roxane COMPAGNON, MD
      • Trélazé, Frankrig, 49800
        • Rekruttering
        • Clinique St Leonard
        • Kontakt:
        • Ledende efterforsker:
          • Audrey ANGELLIAUME, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

11 år til 17 år (Barn)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Adolescents between 11 and 17 years old
  • Adolescent idiopathic scoliosis diagnosis
  • Posterior vertebral fusion surgery indicated to treat the patient
  • Informed consent signed by both parents / legal guardians

Exclusion Criteria:

  • Comorbidities that might influence the duration of hospitalization (e.g. respiratory failure, diabetes…)
  • Previous spine surgery
  • Patient not benefiting from an health insurance plan
  • Pregnant, parturient or breastfeeding woman
  • Patient benefiting of psychiatric care
  • Patient subject to a legal protection measure (guardianship, curatorship)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Experimental group : Improved Recovery After Surgery

Patients in this group will undergo vertebral posterior fusion surgery with the Enhanced recovery after surgery protocol.

This will include at least:

  • A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
  • A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
  • Phone calls from a surgery unit nurse 2 times a day during 5 days
  • A teleconsultation with the surgeon between D3 and D5 following surgery Patients will also have a first consultation with the anesthesist and the surgeon then the surgery will be planned.

They will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

This will include at least:

  • A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
  • A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
  • Phone calls from a surgery unit nurse 2 times a day during 5 days
  • A teleconsultation with the surgeon between D3 and D5 following surgery
Eksperimentel: Control group

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Demonstrate that ERAS in adolescent idiopathic scoliosis compared to standard of care procedure
Tidsramme: At Month 3 (Collected on the day of discharge from surgery hospitalization)

Hospitalization duration measured in days

At Month 3 (Collected on the day of discharge from surgery hospitalization)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Improvement of quality of life at one day after return at home
Tidsramme: Day 1 (VT1) after discharge from surgery hospitalization

Quality of life questionnaires (PedsQL) at day 1 after return at home 4-point scale : 0 if it's never a problem

  1. if it's almost never a problem
  2. if it's sometimes a problem
  3. if it's often a problem
  4. if it's almost always a problem
Day 1 (VT1) after discharge from surgery hospitalization
Improvement of quality of life at 5 days, 45 days and 12 months after return at home
Tidsramme: Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

Quality of life questionnaires (PedsQL) at day 5, day 45 and month 12 after return at home 4-point scale : 0 if it's never a problem

  1. if it's almost never a problem
  2. if it's sometimes a problem
  3. if it's often a problem
  4. if it's almost always a problem
Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization
Changing post-surgical pain during hospitalization
Tidsramme: Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]

Visual analog pain scale during surgery hospitalization 10-point scale: 0: no pain 10: uncontrollable pain

Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]
Changing post-surgical pain at day 1, day 5, day 45 and month 12 after return at home
Tidsramme: Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

Visual analog pain scale 10-point scale: 0: no pain 10: uncontrollable pain

Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization
Changing post-surgical complications at day 45 and month 12
Tidsramme: Day 45 (V4) and month 12 (V5)

Complications after surgery at day 45 and month 12 10-point scale: 0: no pain 10: uncontrollable pain

Day 45 (V4) and month 12 (V5)
Changing the rate of re-hospitalization during the 12 months following surgery
Tidsramme: From day of surgery day 0 (V3) to month 12 (V5)

Re-hospitalization rate during the 12 monts following surgery

From day of surgery day 0 (V3) to month 12 (V5)
Describe the acceptability of the early discharge date from hospitalization in the two arms by patients and their parents
Tidsramme: Day of surgery day 0 (V3)

Percentage of parents refusal for early discharge date

Day of surgery day 0 (V3)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

21. september 2026

Primær færdiggørelse (Anslået)

21. august 2030

Studieafslutning (Anslået)

21. august 2030

Datoer for studieregistrering

Først indsendt

7. marts 2025

Først indsendt, der opfyldte QC-kriterier

26. marts 2025

Først opslået (Faktiske)

3. april 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

24. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

23. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 69HCL23_0742

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .